Assessment of the frequency and costs of posttransplantation hospitalizations in patients receiving tacrolimus versus cyclosporine

American Journal of Kidney Diseases

Volumn 32, Issue 5, 1998, Pages 770-777

  Neylan, J F ^a   Sullivan, E M ^a   Steinwald, B ^a   Goss, T F ^a  

^a Covance Hlth Eco/Outcomes Svcs Inc ^*  (United States)

Author keywords

Cyclosporine; End stage renal disease; Health economics; Hospitalization costs; Immunosuppresion; Kidney transplantation; Tacrolimus

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CADAVER KIDNEY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; FEMALE; HOSPITAL COST; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031737960     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(98)70132-5     Document Type: Article

References (15)